The Institute for Clinical and Economic Review (ICER) has posted its revised Evidence Report assessing the comparative clinical effectiveness and value of sotat 14 November 2023
In a strongly-worded statement, the Hellenic Association of Pharmaceutical Companies (SFEE) has argued against mandatory rebates on drug expenditure. 13 November 2023
The National Institute for Health and Care Excellence (NICE) has recommended Lamzede (velmanase alfa) in its final evaluation document as an option for treating 9 November 2023
Boston, USA-based non-profit the Institute for Clinical and Economic Review (ICER) has published a report on barriers to fair access in the US insurance industr 3 November 2023
In line with a provisional report issued in September, the Boston, USA-based pricing watchdog the Institute for Clinical and Economic Review (ICER) has confirm 31 October 2023
US pharma giant Pfizer has revealed the cost of its oral antiviral treatment for COVID-19, Paxlovid (nirmatrelvir/ritonavir), once the company starts selling th 20 October 2023
If Ireland’s people were not already somewhat pessimistic on Monday following the country’s exit from the Rugby World Cup, they have further reason for gloom, a 16 October 2023
Leading regulatory bodies around the world have various pathways in place to speed up the approval process for promising medicines that offer a solution to unme 6 October 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.